Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q4 2020 · 10-K
Revenue$46.01M$46.01M+71.0% vs Q4 2019 Net Income-$7.48M-$7.48MN/M vs Q4 2019 EPS Diluted-$0.28-$0.28N/M vs Q4 2019 Gross Profit$38,848,000+71.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$4,110,000N/M Free Cash Flowderived-$4,714,000N/M Margins · derivedGross margin84.4%+0.2 pt vs Q4 2019
Operating margin-15.3%+19.2 pt vs Q4 2019
Net margin-16.3%+17.5 pt vs Q4 2019
ended Dec 31, 2020 · filed Feb 24, 2021 · 55 d after period end